Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.1 USD | -6.47% | -5.88% | -26.26% |
Financials (USD)
Sales 2024 * | 29.54M | Sales 2025 * | 186M | Capitalization | 2B |
---|---|---|---|---|---|
Net income 2024 * | -262M | Net income 2025 * | -217M | EV / Sales 2024 * | 62.2 x |
Net cash position 2024 * | 163M | Net cash position 2025 * | 59.29M | EV / Sales 2025 * | 10.5 x |
P/E ratio 2024 * |
-8.31
x | P/E ratio 2025 * |
-11.8
x | Employees | 268 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.43% |
Latest transcript on Rocket Pharmaceuticals, Inc.
1 day | -6.47% | ||
1 week | -5.88% | ||
Current month | -17.97% | ||
1 month | -17.84% | ||
3 months | -22.27% | ||
6 months | +22.64% | ||
Current year | -26.26% |
Managers | Title | Age | Since |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 18-01-03 |
Kinnari Patel
PSD | President | 46 | 18-01-03 |
Chief Tech/Sci/R&D Officer | 60 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 18-01-03 |
Carsten Boess
BRD | Director/Board Member | 57 | 15-12-31 |
David Southwell
BRD | Director/Board Member | 63 | 14-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 2 M€ | -.--% | ||
0.13% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.06% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 22.1 | -6.47% | 957,992 |
24-04-24 | 23.63 | -0.17% | 918,654 |
24-04-23 | 23.67 | -0.84% | 451,559 |
24-04-22 | 23.87 | +4.69% | 570,571 |
24-04-19 | 22.8 | -2.90% | 960,831 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.26% | 2B | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.49% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- RCKT Stock